Skip to content

Total debt at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$211.5M+34.2%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$144.19M
Revvity logo
RevvityRVTY
$3.94B+17.8%
Labcorp Holdings logo
Labcorp HoldingsLH
Quest Diagnostics logo
Quest DiagnosticsDGX
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M-4.5%
Enterprise value$69.6M-0.5%
P/S1,250.3×+560×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Calculated from Sera Prognostics’s reported figures.

Plus components not separately reported this period.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's total debt?
Sera Prognostics (SERA) reported total debt of $2.51M in Q1 2026.
How has Sera Prognostics's total debt changed year-over-year?
Sera Prognostics's total debt increased by 286.0% year-over-year, from $649K to $2.51M.
What is the long-term trend for Sera Prognostics's total debt?
Over 5 years (2020 to 2025), Sera Prognostics's total debt has grown at a -11.9% compound annual growth rate (CAGR), from $4.42M to $2.34M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.